EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis

Yashaswi Guntupalli, Rithish Nimmagadda, Vineeth Potluri, Sameer Kumar Majety, Tejaswi Mangalagiri, Ananya Yendluri, Madhav Changela, Meghana Kakarla, Omar Oudit, Muhammad Hasan

Digestive Diseases · 30.03.2026 · 44 (3) · 280-297

DOI: 10.1159/000551806 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Digestive Diseases, online erschienen am 30.03.2026. Verfasst von Yashaswi Guntupalli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Circulating Tumor DNA, Early Detection of Cancer. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Circulating tumor DNA (ctDNA) assays are emerging as promising noninvasive tools for colorectal cancer (CRC) screening. This updated systematic review and meta-analysis evaluated the diagnostic accuracy of blood-based ctDNA assays for early CRC detection in asymptomatic adults.

Methods

We included prospective and cross-sectional diagnostic accuracy studies comparing ctDNA assays (mutation, methylation, or fragment-based) against colonoscopy or histopathology. Study-level 2 × 2 data were extracted to calculate sensitivity and specificity. Pooled estimates were derived using a Reitsma bivariate random-effects model. Secondary measures like diagnostic odds ratio (DOR), positive and negative likelihood ratios (PLR, NLR), positive predictive value (PPV), and negative predictive value (NPV) were synthesized on transformed scales and back-transformed for reporting. Subgroup analyses by assay type and meta-regression explored heterogeneity. Risk of bias was assessed with QUADAS-2 and certainty of evidence with GRADE.

Results

Ten studies met inclusion criteria, nine contributing to pooled estimates. The pooled sensitivity was 0.887 (95% CI, 0.848–0.920) and specificity 0.913 (95% CI, 0.898–0.928). A sensitivity analysis excluding studies with high risk of bias in patient selection yielded a comparable pooled sensitivity of 0.857 (95% CI, 0.794–0.904) and specificity of 0.900 (95% CI, 0.897–0.904). The SROC curve yielded an AUC of 0.97, indicating excellent discrimination. Secondary pooled metrics included a DOR of 83.9, PLR of 9.2, and NLR of 0.12. PPV was low (99%) at screening prevalences of 0.5–2%. Subgroup analyses by assay type revealed no significant differences in diagnostic accuracy.

Conclusion

Blood-based ctDNA assays show high pooled sensitivity, specificity, and discrimination for CRC detection, but limited predictive value at screening prevalence and study heterogeneity constrain clinical adoption. Large, standardized, population-based studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCirculating Tumor DNAEarly Detection of CancerHumansSensitivity and SpecificityBiomarkers, Tumor

Stichwörter der Autor:innen

Circulating tumor DNAColorectal cancerDiagnostic accuracyEarly detectionMeta-analysisScreening

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Internal Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, India.
  • Department of Internal Medicine, One Brooklyn Health, Brooklyn, New York, USA.
  • Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, USA, potlurv@ccf.org.
  • Department of Clinical Medicine, School of Medicine, Xiamen University, Xiamen, China.
  • Department of General Medicine, Meenakshi Medical College Hospital and Research Institute, Kanchipuram, India.
  • Department of Internal Medicine, Allegheny College, Meadville, Pennsylvania, USA.

Zitieren

APA

Guntupalli, Y., Nimmagadda, R., Potluri, V., Majety, S. K., Mangalagiri, T., Yendluri, A., Changela, M., Kakarla, M., Oudit, O., & Hasan, M. (2026). Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis. Digestive Diseases, 44(3), 280-297. https://doi.org/10.1159/000551806

Vancouver

Guntupalli Y, Nimmagadda R, Potluri V, Majety SK, Mangalagiri T, Yendluri A, et al. Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis. Digestive Diseases. 2026;44(3):280-297. doi:10.1159/000551806

BibTeX
@article{Guntupalli2026,
  author = {Guntupalli, Yashaswi and Nimmagadda, Rithish and Potluri, Vineeth and Majety, Sameer Kumar and Mangalagiri, Tejaswi and Yendluri, Ananya and Changela, Madhav and Kakarla, Meghana and Oudit, Omar and Hasan, Muhammad},
  title = {Blood-Based Circulating Tumor DNA for Early Detection of Colorectal Cancer: A Systematic Review and Meta-Analysis},
  journal = {Digestive Diseases},
  year = {2026},
  volume = {44},
  number = {3},
  pages = {280--297},
  doi = {10.1159/000551806}
}
Kostenlos starten →